These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33181644)

  • 1. Efficacy and safety of evocalcet in treatment of secondary hyperparathyroidism in chronic kidney disease on hemodialysis patients: A protocol for a systematic review and meta-analysis.
    Xie J; Li X; Chen Y; Chen M; Mao N; Fan J
    Medicine (Baltimore); 2020 Nov; 99(46):e22566. PubMed ID: 33181644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Fukagawa M; Shimazaki R; Akizawa T;
    Kidney Int; 2018 Oct; 94(4):818-825. PubMed ID: 30049473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis.
    Palmer SC; Mavridis D; Johnson DW; Tonelli M; Ruospo M; Strippoli GFM
    Am J Kidney Dis; 2020 Sep; 76(3):321-330. PubMed ID: 32475604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of evocalcet for unmet needs among calcimimetic agents.
    Hamano N; Endo Y; Kawata T; Fukagawa M
    Expert Rev Endocrinol Metab; 2020 Sep; 15(5):299-310. PubMed ID: 32552012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism.
    Akizawa T; Ikejiri K; Kondo Y; Endo Y; Fukagawa M
    Ther Apher Dial; 2020 Jun; 24(3):248-257. PubMed ID: 31486206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis.
    Yokoyama K; Shimazaki R; Fukagawa M; Akizawa T;
    Sci Rep; 2019 Apr; 9(1):6410. PubMed ID: 31015494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients.
    Shigematsu T; Shimazaki R; Fukagawa M; Akizawa T;
    Clin Exp Nephrol; 2019 Feb; 23(2):258-267. PubMed ID: 30159688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
    Liu Y; Yang Q; Chen G; Zhou T
    Curr Pharm Des; 2022; 28(40):3289-3304. PubMed ID: 36305135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
    Sakai M; Tokunaga S; Kawai M; Murai M; Kobayashi M; Kitayama T; Saeki S; Kawata T
    PLoS One; 2020; 15(4):e0232428. PubMed ID: 32343734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological and clinical profiles of a novel calcimimetic, evocalcet (ORKEDIA
    Tokunaga S; Endo Y; Kawata T
    Nihon Yakurigaku Zasshi; 2019; 154(1):35-43. PubMed ID: 31308348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials.
    Xu J; Yang Y; Ma L; Fu P; Peng H
    Int Urol Nephrol; 2019 Nov; 51(11):2027-2036. PubMed ID: 31531805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients.
    Tsuruya K; Shimazaki R; Fukagawa M; Akizawa T;
    Clin Exp Nephrol; 2019 Jun; 23(6):739-748. PubMed ID: 30955188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study.
    Akizawa T; Shimazaki R; Fukagawa M;
    PLoS One; 2018; 13(10):e0204896. PubMed ID: 30379826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of core stability exercise for patients with neck pain: A protocol for systematic review and meta-analysis.
    He Y; Sun W; Zhao X; Ma M; Zheng Z; Xu L
    Medicine (Baltimore); 2019 Nov; 98(46):e17240. PubMed ID: 31725601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis.
    Li D; Shao L; Zhou H; Jiang W; Zhang W; Xu Y
    Endocrine; 2013 Feb; 43(1):68-77. PubMed ID: 22669774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism.
    Shigematsu T; Asada S; Endo Y; Kawata T; Fukagawa M; Akizawa T
    PLoS One; 2022; 17(2):e0262829. PubMed ID: 35176038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
    Ballinger AE; Palmer SC; Nistor I; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2014; 2014(12):CD006254. PubMed ID: 25490118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.
    Lozano-Ortega G; Waser N; Bensink ME; Goring S; Bennett H; Block GA; Chertow GM; Trotman ML; Cooper K; Levy AR; Belozeroff V
    J Comp Eff Res; 2018 Jul; 7(7):693-707. PubMed ID: 29762046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis.
    Zhang Q; Li M; You L; Li H; Ni L; Gu Y; Hao C; Chen J
    PLoS One; 2012; 7(10):e48070. PubMed ID: 23133549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.